HBTA vs CURE
Comparison between HORIZON EXPEDITION PLUS ETF (HBTA, ETF) and DIREXION DAILY HEALTHCARE BULL 3X SHARES (CURE, ETF).
HBTA vs CURE - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Net Assets
Winner
HBTA
$139M
CURE
$138M
Expense Ratio
HBTA
0.86%
CURE
N/A
Max Drawdown
Winner
HBTA
26.73%
CURE
69.19%
Sharpe Ratio
Winner
HBTA
1.49
CURE
0.80
5Y Beta
Winner
HBTA
1.34
CURE
1.38
P/E Ratio
HBTA
33.62
Winner
CURE
28.04
Forward P/E
HBTA
25.10
Winner
CURE
17.34
PEG Ratio
HBTA
0.37
CURE
N/A
5Y Dividends CAGR
HBTA
N/A
CURE
63.21%
5Y EPS CAGR
Winner
HBTA
30.19%
CURE
12.58%
Debt to Equity
Winner
HBTA
42.05%
CURE
53.58%
P/S Ratio
HBTA
4.54
Winner
CURE
1.48
P/B Ratio
HBTA
7.35
Winner
CURE
4.58
HBTA vs CURE - Holdings Comparison
HBTA and CURE have 18 common holdings. Overlap is 2.37%
HBTA's top 25 holdings weight is 63.15%. CURE's top 25 holdings weight is 91.92%.
| Rank | HBTA | CURE |
|---|---|---|
| #1 | ROUNDHILL MAGNIFICENT SEVEN ETF (MAGS) - 8.83% | GOLDMAN FINL SQ TRSRY INST 506 (n/a) - 12.35% |
| #2 | NVIDIA CORP (NVDA) - 8.36% | ELI LILLY AND CO (LLY) - 11.75% |
| #3 | ALPHABET INC CLASS A (GOOGL) - 7.74% | DREYFUS GOVT CASH MAN INS (n/a) - 10.69% |
| #4 | APPLE INC (AAPL) - 7.10% | JOHNSON & JOHNSON (JNJ) - 7.72% |
| #5 | BROADCOM INC (AVGO) - 4.43% | GOLDMAN SACHS FIN GOV 465 INSTITUT (n/a) - 7.02% |
| #6 | AMAZON.COM INC (AMZN) - 3.06% | ABBVIE INC (ABBV) - 5.24% |
| #7 | TESLA INC (TSLA) - 2.59% | UNITEDHEALTH GROUP INC (UNH) - 4.75% |
| #8 | MICRON TECHNOLOGY INC (MU) - 2.11% | MERCK & CO INC (MRK) - 4.14% |
| #9 | META PLATFORMS INC CLASS A (META) - 1.94% | AMGEN INC (AMGN) - 2.52% |
| #10 | ADVANCED MICRO DEVICES INC (AMD) - 1.71% | THERMO FISHER SCIENTIFIC INC (TMO) - 2.34% |
| #11 | WALMART INC (WMT) - 1.65% | GILEAD SCIENCES INC (GILD) - 2.31% |
| #12 | ELI LILLY AND CO (LLY) - 1.65% | INTUITIVE SURGICAL INC (ISRG) - 2.16% |
| #13 | MICROSOFT CORP (MSFT) - 1.53% | ABBOTT LABORATORIES (ABT) - 2.10% |
| #14 | INTEL CORP (INTC) - 1.17% | PFIZER INC (PFE) - 2.05% |
| #15 | EXXON MOBIL CORP (XOM) - 1.11% | BRISTOL-MYERS SQUIBB CO (BMY) - 1.65% |
| #16 | CATERPILLAR INC (CAT) - 1.01% | CVS HEALTH CORP (CVS) - 1.61% |
| #17 | LAM RESEARCH CORP (LRCX) - 0.92% | VERTEX PHARMACEUTICALS INC (VRTX) - 1.54% |
| #18 | JOHNSON & JOHNSON (JNJ) - 0.86% | DANAHER CORP (DHR) - 1.51% |
| #19 | APPLIED MATERIALS INC (AMAT) - 0.82% | STRYKER CORP (SYK) - 1.50% |
| #20 | GE AEROSPACE (GE) - 0.81% | MEDTRONIC PLC (MDT) - 1.38% |
| #21 | n/a (PLTR) - 0.78% | MCKESSON CORP (MCK) - 1.29% |
| #22 | THE GOLDMAN SACHS GROUP INC (GS) - 0.76% | BOSTON SCIENTIFIC CORP (BSX) - 1.19% |
| #23 | GE VERNOVA INC (GEV) - 0.74% | ELEVANCE HEALTH INC (ELV) - 1.19% |
| #24 | ORACLE CORP (ORCL) - 0.74% | THE CIGNA GROUP (CI) - 1.03% |
| #25 | MORGAN STANLEY (MS) - 0.73% | REGENERON PHARMACEUTICALS INC (REGN) - 0.89% |
| Total Holdings | 206 | 65 |
HBTA vs CURE - Historical Returns
Returns include dividend reinvestment.
1M
HBTA
+1.87%
Winner
CURE
+14.77%
3M
Winner
HBTA
+10.85%
CURE
-5.02%
6M
Winner
HBTA
+9.50%
CURE
-6.22%
1Y
HBTA
+33.81%
Winner
CURE
+34.45%
5Y(CAGR)
HBTA
N/A
CURE
+2.34%
10Y(CAGR)
HBTA
N/A
CURE
+12.66%
Max(CAGR)
HBTA
+18.32%
Winner
CURE
+23.14%
HBTA vs CURE - Annual Returns (2011 - 2026)
Returns include dividend reinvestment.
| Year | HBTA | CURE |
|---|---|---|
| 2026 | +9.60% | -10.45% |
| 2025 | +14.69% | +22.87% |
| 2024 | N/A | -12.90% |
| 2023 | N/A | -8.46% |
| 2022 | N/A | -17.91% |
| 2021 | N/A | +90.55% |
| 2020 | N/A | +4.13% |
| 2019 | N/A | +62.36% |
| 2018 | N/A | -0.75% |
| 2017 | N/A | +62.77% |
| 2016 | N/A | -12.42% |
| 2015 | N/A | +6.24% |
| 2014 | N/A | +83.03% |
| 2013 | N/A | +153.15% |
| 2012 | N/A | +45.79% |
| 2011 | N/A | -9.68% |
HBTA vs CURE Drawdown Comparison
The maximum drawdown for HBTA was -26.73%, occurring on Apr 8, 2025. Recovery took 93 trading sessions.
The maximum drawdown for CURE was -69.19%, occurring on Mar 23, 2020. Recovery took 242 trading sessions.
The current HBTA drawdown is -4.50%. The current CURE drawdown is -28.04%.
| Rank | HBTA | CURE |
|---|---|---|
| #1 | -26.73% Feb 19, 2025 - Jul 3, 2025 | -69.19% Jan 22, 2020 - Jan 6, 2021 |
| #2 | -13.18% Jan 29, 2026 - Apr 15, 2026 | -52.25% Apr 8, 2022 - Aug 7, 2025 |
| #3 | -7.03% Oct 29, 2025 - Dec 24, 2025 | -48.54% Jul 20, 2015 - Jun 22, 2017 |
| #4 | -4.50% Jun 2, 2026 - Jun 5, 2026 | -44.44% Jul 1, 2011 - Mar 15, 2012 |
| #5 | -3.71% Oct 8, 2025 - Oct 20, 2025 | -42.27% Oct 1, 2018 - Nov 27, 2019 |
| #6 | -3.55% May 14, 2026 - May 26, 2026 | -36.35% Jan 26, 2018 - Sep 13, 2018 |
| #7 | -3.48% Jan 12, 2026 - Jan 29, 2026 | -29.28% Dec 30, 2021 - Apr 8, 2022 |
| #8 | -3.36% Jan 23, 2025 - Feb 14, 2025 | -22.89% Aug 17, 2021 - Dec 15, 2021 |
| #9 | -2.92% Jul 28, 2025 - Aug 8, 2025 | -22.59% Sep 24, 2014 - Oct 28, 2014 |
| #10 | -2.46% Aug 14, 2025 - Aug 27, 2025 | -19.78% Mar 4, 2014 - Jun 19, 2014 |
| #11 | -1.76% Sep 22, 2025 - Oct 6, 2025 | -19.31% Oct 17, 2012 - Jan 9, 2013 |
| #12 | -1.66% Aug 28, 2025 - Sep 8, 2025 | -19.31% Jan 20, 2021 - Apr 15, 2021 |
| #13 | -1.60% Jul 3, 2025 - Jul 14, 2025 | -17.38% Apr 2, 2012 - Jun 29, 2012 |
| #14 | -1.48% Dec 26, 2025 - Jan 6, 2026 | -15.49% May 28, 2013 - Jul 12, 2013 |
| #15 | -1.05% Apr 17, 2026 - Apr 22, 2026 | -14.96% Dec 8, 2014 - Jan 22, 2015 |
Correlation
Correlation between HBTA and CURE is 0.17 which considered as a very weak or no correlation - the stocks move independently of each other.
0.17
-101
Dividend Comparison (2011 - 2026)
HBTA vs CURE dividend yield comparison.
| Year | HBTA | CURE |
|---|---|---|
| 2026 | 0.00% | 0.28% |
| 2025 | 0.64% | 1.12% |
| 2024 | 0.00% | 1.17% |
| 2023 | 0.00% | 2.02% |
| 2022 | 0.00% | 0.38% |
| 2021 | 0.00% | 0.02% |
| 2020 | 0.00% | 0.17% |
| 2019 | 0.00% | 0.40% |
| 2018 | 0.00% | 0.70% |
| 2017 | 0.00% | 0.18% |
| 2013 | 0.00% | 1.24% |
| 2012 | 0.00% | 0.03% |
| 2011 | 0.00% | 2.10% |
Select Stocks to Compare
Popular: HBTA vs SPYCURE vs SPY
More Comparisons
Compare with similar stocks